What are the main goals of the UAE cancer association what potential collaboration with BCU?
oncologist, UAE
New User? Click here to register
Prof Wahib Boubnider, General Surgery Centre Pierre et Marie Curie, Alger, Algeria
Surgical treatment of HER2 (3+) breast cancer is now part of a perioperative chemotherapy strategy. It allows an increase in breast conservation and sometimes even in the recurrence-free survival of patients in the event of complete histological non-response (pCR). Nevertheless, this benefit is poorly evaluated for tumors less than 2 cm, without lymph node involvement and surgical abstention in the event of (pCR) is not yet possible in current practice, due to the performance limits of imaging and resections by macro biopsies.
Text generated by AI based on an exclusive interview, revised and reviewed by
Yazid BELKACEMI
Radiotherapeute, Paris, France
Joseph GLIGOROV
Oncologue, Paris, France
Copyright © 2026 - BCU